Literature DB >> 19618435

Clinical and genetic analysis of Korean patients with congenital insensitivity to pain with anhidrosis.

Seung-Tae Lee1, Jeehun Lee, Munhyang Lee, Jong-Won Kim, Chang-Seok Ki.   

Abstract

Congenital insensitivity to pain with anhidrosis (CIPA) is a rare autosomal recessive disease characterized by anhidrosis, insensitivity to noxious stimuli, and mental retardation. Mutations in the NTRK1 gene are associated with the pathogenesis of CIPA. In this study, we performed a clinical and genetic analysis on the NTRK1 gene in four Korean patients with CIPA. All patients had typical clinical manifestations of CIPA, including anhidrosis, recurrent fever, absent pain perception, and developmental delay. Sequencing analysis revealed one predominant mutation, c.851-33T>A, in four affected alleles and three novel mutations, including c.287+2dupT, c.2155G>A (p.Glu719Lys), and c.1218delC (p.Pro407ArgfsX), in each affected allele. For one patient, who was heterozygous for c.851-33T>A, another mutation could not be identified, suggesting that a possible hidden intronic or large genomic mutation may have been present. This study extends the spectrum of mutations in the NTRK1 gene and confirms that Korean patients with CIPA have the same genetic background as other ethnicities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19618435     DOI: 10.1002/mus.21340

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  8 in total

Review 1.  Mechanisms of disease in hereditary sensory and autonomic neuropathies.

Authors:  Annelies Rotthier; Jonathan Baets; Vincent Timmerman; Katrien Janssens
Journal:  Nat Rev Neurol       Date:  2012-01-24       Impact factor: 42.937

2.  A short in-frame deletion in NTRK1 tyrosine kinase domain caused by a novel splice site mutation in a patient with congenital insensitivity to pain with anhidrosis.

Authors:  Esther Sarasola; Jose A Rodríguez; Elisa Garrote; Javier Arístegui; Maria J García-Barcina
Journal:  BMC Med Genet       Date:  2011-06-27       Impact factor: 2.103

Review 3.  Interpretation of mRNA splicing mutations in genetic disease: review of the literature and guidelines for information-theoretical analysis.

Authors:  Natasha Caminsky; Eliseos J Mucaki; Peter K Rogan
Journal:  F1000Res       Date:  2014-11-18

4.  Identification of a novel nonsense mutation of the neurotrophic tyrosine kinase receptor type 1 gene in two siblings with congenital insensitivity to pain with anhidrosis.

Authors:  Ting Wang; Haibo Li; Jingjing Xiang; Bin Wei; Qin Zhang; Qin Zhu; Minjuan Liu; Miao Sun; Hong Li
Journal:  J Int Med Res       Date:  2017-03-27       Impact factor: 1.671

5.  Heterogeneity of clinical features and mutation analysis of NTRK1 in Han Chinese patients with congenital insensitivity to pain with anhidrosis.

Authors:  Ningbo Li; Shanna Guo; Qingli Wang; Guangyou Duan; Jiaoli Sun; Yi Liu; Jin Zhang; Cong Wang; Changmao Zhu; Jingyu Liu; Xianwei Zhang
Journal:  J Pain Res       Date:  2019-01-22       Impact factor: 3.133

6.  Identification of novel variations in the NTRK1 gene causing congenital insensitivity to pain with anhidrosis.

Authors:  Shang Li; Hua-Ying Hu; Jun-Jun Xu; Zhan-Ke Feng; Yong-Qing Sun; Xu Chen; Kai Yang; Ya-Zhou Li; Dong-Liang Zhang
Journal:  Mol Genet Genomic Med       Date:  2021-10-21       Impact factor: 2.183

7.  Novel NTRK1 mutations in Chinese patients with congenital insensitivity to pain with anhidrosis.

Authors:  Xingzhu Geng; Yanshan Liu; XiuZhi Ren; Yun Guan; Yanzhou Wang; Bin Mao; Xiuli Zhao; Xue Zhang
Journal:  Mol Pain       Date:  2018-05-17       Impact factor: 3.395

Review 8.  Phenotypic heterogeneity of intellectual disability in patients with congenital insensitivity to pain with anhidrosis: A case report and literature review.

Authors:  Zhenlei Liu; Jiaqi Liu; Gang Liu; Wenjian Cao; Sen Liu; Yixin Chen; Yuzhi Zuo; Weisheng Chen; Jun Chen; Yu Zhang; Shishu Huang; Guixing Qiu; Philip F Giampietro; Feng Zhang; Zhihong Wu; Nan Wu
Journal:  J Int Med Res       Date:  2018-04-05       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.